PRIMECAP Management's position in Astrazeneca plc is currently worth $3.31 Billion. That's 2.46% of their equity portfolio (8th largest holding). The investor owns 1.41% of the outstanding Astrazeneca plc stock. The first Astrazeneca plc trade was made in Q3 2015. Since then PRIMECAP Management bought shares seventeen more times and sold shares on sixteen occasions. The stake costed the investor $1.37 Billion, netting the investor a gain of 141% so far.
Princeton Global Asset Management LLC grew its position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 77.5% during the third quarter, according ...
The AM Reporter, 4 months agoFirst enrollment and first subject dosing expected soon at Erasmus Medical Center in Rotterdam, Netherlands Management discusses the announcement and what th...
Finanz Nachrichten, 4 months agoMoran Wealth Management LLC decreased its position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 1.4% in the 2nd quarter, Holdings Channel repor...
The AM Reporter, 6 months agoIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) looks set to end its losing streak. At the time of writing, the benchmark index is up 0.5% to 7,116 poi...
Newswires, 11 months ago